NSF_4-Color_bitmap_Logo.png

ACCUBREATH INC. AWARDED $1,000,000 NSF FUNDING

AccuBreath Inc. Awarded $1,000,000 NSF Funding for Innovative Ventilator Development


SILICON SLOPES, UT, 12 April 2022 – AccuBreath Inc. has received a $1,000,000 grant from the National Science Foundation (NSF) for a Phase II project to continue development of the AccuBreathEMS, a portable device that ventilates, monitors and supports patients’ breathing during medical emergencies and transport.


This funding program is highly competitive, and applications go through a rigorous vetting process for both technical impact and business potential. AccuBreath was granted this award for its work to improve the healthcare provided to patients needing airway support during emergency situations. AccuBreathEMS is designed to replace a bag-valve-mask (BVM) device, the current standard of care, and can support an airway without requiring endotracheal intubation.


“The standard of care for emergency rescue ventilation hasn’t changed much in decades. AccuBreath hopes to revolutionize the tools used by first responders to enable them to perform their job faster, safer, and more effectively,” said Dr. Michael Fogarty, Co-Founder and CTO. “Every second matters in these life or death situations and AccuBreathEMS has been designed to magnify and augment the highly specialized skill set of first responders.” said. Spencer Madsen, Co-Founder and CEO. 


Fogarty and Madsen co-founded the company in 2017, while studying biomedical engineering at the University of Utah. The patented technology behind AccuBreath was Dr. Fogarty’s primary research for over 5 years. Its core technology has spawned additional patents and medical applications that are currently in the works.


AccuBreath’s Phase II award came through the federal Small Business Innovation Research (SBIR) program, where the company previously received a $225,000 NSF Phase I award. The Utah Innovation Center assisted AccuBreath with these winning proposals and is available to assist other Utah companies looking for non-dilutive funding through the federal SBIR/STTR programs.

 
 
Spencer_TimesSquare_edited.jpg

NASDAQ Milestone Makers

September 9, 2020

CEO of AccuBreath, Spencer Madsen, graduated from the NASDAQ Milestone Makers and was featured on the NASDAQ building in Times Square. 

The following video was produced as part of the graduation process. 

https://drive.google.com/file/d/1C-B9YyGvcyno5PcO91_Ka_4gLSgXsuJ8/view

unnamed.jpg

AccuBreath Featured on Local News

May 12, 2020

Utahns making portable ventilators that could treat people with COVID-19

https://www.fox13now.com/utahns-making-portable-ventilators-that-could-treat-people-with-covid-19

NSF_4-Color_bitmap_Logo.png

AccuBreath Wins NSF SBIR Phase 1 Grant - $225k

January 1, 2020

AccuBreath is thrilled to join America’s Seed Fund, powered by the National Science Foundation - also known as the Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) program. As a Phase I awardee, we have joined an elite group of about 2500 other deep-technology small businesses and start-ups (just over the last decade!) that includes many of the most innovative and promising ventures in the country.

To learn more about America’s Seed Fund powered by NSF, visit: https://seedfund.nsf.gov/

Presentation1.jpg

AccuBreath Connects with Institutional Lead Investor

September 6, 2019

Ideaship, part of the Global Technology Transfer Group (GTT) and the Panasonic IP Corporation of America, have made a lead investment of $100k in AccuBreath and the further development and protection of intellectual property. The validation from a group like Ideaship of AccuBreath's IP is crucial, as well as their ongoing support. The GTT group touches 56% of all IP transactions in the US. 

www.ideashipfund.com